Navigation Links
Inverness Medical Innovations to Pay April Series B Dividend in Additional Shares of Series B Stock
Date:3/19/2009

WALTHAM, Mass., March 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, intends to pay, to the extent declared, dividends payable April 15, 2009, on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB) in shares of Series B stock. Inverness will pay cash in lieu of any fractional shares resulting from the dividend.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
2. Inverness Medical Innovations Announces Fourth Quarter 2008 Results
3. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
4. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
5. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
6. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
7. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
8. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
9. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
10. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
11. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading medical ... No. 9,038,640 by the United States Patent and Trademark Office. The patent applies ... Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety of ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine ... catheters available on the market," said an inventor from Center Valley, Pa. "My idea ... the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an ...
(Date:7/21/2017)... FL (PRWEB) , ... July 21, 2017 , ... ... insurance management assistance and financial planning services to families and business owners in ... charity event that promises to provide support to area adults with developmental challenges. ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Theater of Witness , was awarded a $300,000 grant from The Pew Center ... empathy, comfort with ambiguity and the recognition of one’s own limits among health ...
(Date:7/21/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has written a ... and pleads with world leaders to be more open about positive changes. Yisrayl says the ... there is a peaceful and positive way to solve all; yes, all issues, and he ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., the ... testing, strengthening and rehabilitation equipment, today announced the national ... MedX is considered the gold standard for the treatment ... specialized medical strengthening equipment. ... with the physician or practice who prescribe the MedX ...
(Date:7/14/2017)... Endo International plc (NASDAQ: ENDP ) will ... Members of its senior management team will host a conference call ... ET. The dial-in number to access the call ... and the passcode is 45397076. Please dial in 10 minutes prior ... A replay of the call will be available from August ...
Breaking Medicine Technology: